Results 221 to 230 of about 51,205 (281)

Development of a Predictive Tool in Patients With High Pretest Probability for Transthyretin Amyloid Cardiomyopathy. [PDF]

JACC Adv
Chai J, Starovoytov A, Worsley D, Fine NM, Peng D, Virani S, Davis MK.   +6 more
europepmc   +1 more source

Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A Multicentric, Prospective Pilot Study for AMY-CCM Registry

Procolo Marchese, Francesca Gennaro, Giovanni Mazzotta, Pierfrancesco Grossi, L Cocchiara, Stefano Guarracini, L Mazzocchetti, Matteo Ziacchi, Mauro Biffi, R Magnano, Massimo Di Marco, Matteo Ruzzolini, Antonio Bisignani, Matteo Bianco, Paolo Garrone, Walter Grosso Marra, Margherita Cannillo, Carlo Lavalle, Daniele Masarone, Cristina Chimenti   +19 more
openalex   +1 more source

Amyloidogenic phenotypical variation affects post-transplant outcome of hereditary transthyretin amyloidosis: a retrospective study. [PDF]

eGastroenterology
Wilczek HE, Tranäng M, Coelho T, Ericzon BG.   +3 more
europepmc   +1 more source

Investigation of Acoramidis-based ionic liquids as potential stabilizers of transthyretin using DFT calculations, molecular docking, and ADMET studies. [PDF]

Sci Rep
Mostaghni F, Mahani NM.
europepmc   +1 more source

Clinical and genetic analysis of a family with transthyretin amyloid polyneuropathy caused by a TTR Lys55Asn mutation

Nannan Qian, Taohua Wei, Yufei Qian, Wenming Yang, Hui Han, Huaizhen Chen, Jun Li   +6 more
openalex   +1 more source

Central Nervous System Manifestations Associated with Hereditary Transthyretin Amyloidosis: a Narrative Review. [PDF]

Arq Neuropsiquiatr
Costa PIMCA, Cruzeiro MM, Galil AGS, Vale TC.   +3 more
europepmc   +1 more source

Transthyretin Cardiac Amyloidosis and Heart Failure: State-of-the-Art Review and Practice Guidance. [PDF]

Rev Cardiovasc Med
Bukhari S, Hamza M, Malik A.
europepmc   +1 more source

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.

JAMA Cardiol
Soman P, Cuddy SAM, Gillmore JD, Sarswat N, Judge DP, Cappelli F, Stern LK, Wright R, Akinboboye O, Obici L, Bhatt K, Xiong K, Castaño A, Chen C, Falvey H, Pecoraro ML, Tamby JF, Sinha U, Fox JC, Shah K, Grodin JL, Ambardekar AV, Alexander KM, Khouri MG, Cheng RK.   +24 more
europepmc   +1 more source

Multimodal Diagnosis of Cardiac Amyloidosis: Integrating Imaging, Histochemistry, and Proteomics of Precise Typing. [PDF]

Int J Mol Sci
Kancerek J, Zniszczoł Ł, Lewandowski P, Wojnicz R.   +3 more
europepmc   +1 more source